Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.

A simple method for displaying the hydropathic character of a protein

Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,927

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431

Empirical Predictions of Protein Conformation

Chou, P. Y., & Fasman, G. D. (1978) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.47.070178.001343 · Cited by 3,099

Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing

Rosenfeld, M. G., Mermod, J.-J., Amara, S. G., Swanson, L. W., Sawchenko, P. E., Rivier, J., Vale, W. W., & Evans, R. M. (1983) · Nature · doi:10.1038/304129a0 · Cited by 2,302

A gas-liquid solid phase peptide and protein sequenator.

Hewick, R. M., Hunkapiller, M. W., Hood, L., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218

Calcitonin gene-related peptide is a potent vasodilator

Brain, S. D., Williams, T. J., Tippins, J. R., Morris, H. R., & MacIntyre, I. M. (1985) · Nature · doi:10.1038/313054a0 · Cited by 2,085

Atlas of Protein Sequence and Structure, 1966.

Hersh, R. T., Eck, R. V., & Dayhoff, M. O. (1967) · Systematic Zoology · doi:10.2307/2412074 · Cited by 1,798

Amino acid analysis by reverse-phase high-performance liquid chromatography: Precolumn derivatization with phenylisothiocyanate

Heinrikson, R. L., & Meredith, S. C. (1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90307-5 · Cited by 1,631

Characterization and Chromosomal Localization of a cDNA Encoding Brain Amyloid of Alzheimer's Disease

Goldgaber, D., Lerman, M. I., McBride, O. W., Saffiotti, U., & Gajdusek, D. C. (1987) · Science · doi:10.1126/science.3810169 · Cited by 1,359

β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011

Inflammasomes: mechanism of action, role in disease, and therapeutics

Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes

Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417

Intrinsically Disordered Proteins in Human Diseases: Introducing the D 2 Concept

Uversky, V. N., Oldfield, C. J., & Dunker, A. K. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125924 · Cited by 1,447

Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus

Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330

Calcitonin Gene-Related Peptide: Physiology and Pathophysiology

Russell, F. A., King, R., Smillie, S.-J., Kodji, X., & Brain, S. D. (2014) · Physiological Reviews · doi:10.1152/physrev.00034.2013 · Cited by 1,321

Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes

Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., & Parrott, M. A. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.436 · Cited by 1,132

Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus

Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044

Conformational constraints for amyloid fibrillation: the importance of being unfolded

Uversky, V. N., & Fink, A. L. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.12.008 · Cited by 1,022

Increased Risk of Type 2 Diabetes in Alzheimer Disease

Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950

CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation

Sheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935

Cognitive Dysfunction and Diabetes Mellitus

Kodl, C. T., & Seaquist, E. R. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0034 · Cited by 846

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

Lorenzo, A., Razzaboni, B. L., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 820

Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.

Westermark, P., Engström, U., Johnson, K. H., Westermark, G. T., & Betsholtz, C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5036 · Cited by 807

International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors

Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804

Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin

Brain, S. D., & Grant, A. D. (2004) · Physiological Reviews · doi:10.1152/physrev.00037.2003 · Cited by 765

Risk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort Study

Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C., & Palumbo, P. J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009106 · Cited by 700

The Importance of -Cell Failure in the Development and Progression of Type 2 Diabetes

Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 710

Endoplasmic Reticulum Stress and Type 2 Diabetes

Back, S. H., & Kaufman, R. J. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072909-095555 · Cited by 636

Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis

Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 622

Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes

Hull, R. L., Westermark, G. T., Westermark, P., & Kahn, S. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0405 · Cited by 592

Peptide Conformation and Supramolecular Organization in Amylin Fibrils: Constraints from Solid-State NMR

Luca, S., Yau, W., Leapman, R. D., & Tycko, R. (2007) · Biochemistry · doi:10.1021/bi701427q · Cited by 584

Glucose Metabolism and Regulation: Beyond Insulin and Glucagon

Aronoff, S. L., Berkowitz, K. J., Schreiner, B., & Want, L. L. (2004) · Diabetes Spectrum · doi:10.2337/diaspect.17.3.183 · Cited by 607

Type 2 diabetes mellitus, cognitive impairment and dementia

Stewart, R., & Liolitsa, D. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00027.x · Cited by 562

Molecular dynamics simulations and novel drug discovery

Liu, X., Shi, D., Zhou, S., Liu, H., Liu, H., & Yao, X. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1403419 · Cited by 539

Neuroanatomical Localization, Pharmacological Characterization and Functions of CGRP, Related Peptides and Their Receptors

van Rossum, D., Hanisch, U., & Quirion, R. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00023-1 · Cited by 517

Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro

Leighton, B., & Cooper, G. J. S. (1988) · Nature · doi:10.1038/335632a0 · Cited by 473

Pathogenesis of Type 2 Diabetes Mellitus

Leahy, J. L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.003 · Cited by 469

Small Bioactive Peptides for Biomaterials Design and Therapeutics

Hamley, I. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00522 · Cited by 466

Evidence of Cosecretion of Islet Amyloid Polypeptide and Insulin by β-Cells

Kahn, S. E., D'Alessio, D. A., Schwartz, M. W., Fujimoto, W. Y., Ensinck, J. W., Taborsky, G. J., & Porte, D. (1990) · Diabetes · doi:10.2337/diab.39.5.634 · Cited by 454

Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin

Mirzabekov, T. A., Lin, M., & Kagan, B. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1988 · Cited by 442

Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.

Tenidis, K., Waldner, M., Bernhagen, J., Fischle, W., Bergmann, M., Weber, M., Merkle, M.-L., Voelter, W., Brunner, H., & Kapurniotu, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3422 · Cited by 401

Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide

Rosenfeld, R., & Gazit, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102883200 · Cited by 421

The New Biology and Pharmacology of Glucagon

Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419

Amylin: Pharmacology, Physiology, and Clinical Potential

Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400

Amyloid peptides are toxic via a common oxidative mechanism.

Schubert, D. A., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., & Kimura, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.1989 · Cited by 382

Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets

Lukinius, A., Wilander, E., Westermark, G. T., Engstr�m, U., & Westermark, P. (1989) · Diabetologia · doi:10.1007/bf00285291 · Cited by 371

Common pathological processes in Alzheimer disease and type 2 diabetes: A review

Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367

Islet inflammation in type 2 diabetes and physiology

Eguchi, K., & Nagai, R. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88877 · Cited by 368

Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle.

Cooper, G. J. S., Leighton, B., Dimitriadis, G., Parry‐Billings, M., Kowalchuk, J. M., Howland, K., Rothbard, J. B., Willis, A. C., & Reid, K. B. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7763 · Cited by 351

Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in Vitro

Kayed, R., Bernhagen, J., Greenfield, N. J., Sweimeh, K., Brunner, H., Voelter, W., & Kapurniotu, A. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2646 · Cited by 351

Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease

Zhao, W.-Q., & Townsend, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.014 · Cited by 291

β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition

Jurgens, C. A., Toukatly, M. N., Fligner, C. L., Udayasankar, J., Subramanian, S. L., Zraika, S., Aston-Mourney, K., Carr, D. B., Westermark, P., Westermark, G. T., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.02.036 · Cited by 329

Effects of Meal Ingestion on Plasma Amylin Concentration in NIDDM and Nondiabetic Humans

Butler, P. C., Chou, J., Carter, W. B., Wang, Y.-N., Bu, B.-H., Chang, D., Chang, J.-K., & Rizza, R. A. (1990) · Diabetes · doi:10.2337/diab.39.6.752 · Cited by 330

Watching amyloid fibrils grow by time-lapse atomic force microscopy 1 1Edited by W. Baumeister

Goldsbury, C. S., Kistler, J., Aebi, U., Arvinte, T., & Cooper, G. J. S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2299 · Cited by 324

Atomic structure of the cross‐β spine of islet amyloid polypeptide (amylin)

Wiltzius, J. J. W., Sievers, S. A., Sawaya, M. R., Cascio, D., Popov, D., Riekel, C., & Eisenberg, D. S. (2008) · Protein Science · doi:10.1110/ps.036509.108 · Cited by 326

Amyloid Fibril Formation from Full-Length and Fragments of Amylin

Goldsbury, C. S., Goldie, K. N., Pellaud, J., Seelig, J., Frey, P., Müller, S. A., Kistler, J., Cooper, G. J. S., & Aebi, U. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4268 · Cited by 316

Protein folding revisited. A polypeptide chain at the folding ? misfolding ? nonfolding cross-roads: which way to go?

Uversky, V. N. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3096-6 · Cited by 322

Islet β cell mass in diabetes and how it relates to function, birth, and death

Weir, G. C., & Bonner‐Weir, S. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12031 · Cited by 296

Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins

Munishkina, L. A., & Fink, A. L. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.03.015 · Cited by 297

Polymorphic Fibrillar Assembly of Human Amylin

Goldsbury, C. S., Cooper, G. J. S., Goldie, K. N., Müller, S. A., Saafi, E. L., Gruijters, W. T. M., Misur, M. P., Engel, A. H., Aebi, U., & Kistler, J. (1997) · Journal of Structural Biology · doi:10.1006/jsbi.1997.3858 · Cited by 293

Focus on the Role of NLRP3 Inflammasome in Diseases

Fusco, R., Siracusa, R., Genovese, T., Cuzzocrea, S., & Paola, R. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124223 · Cited by 293

The role of G protein-coupled receptors in the pathology of Alzheimer's disease

Thathiah, A., & De Strooper, B. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2977 · Cited by 288

Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution

Shim, S., Gupta, R., Ling, Y. L., Strasfeld, D. B., Raleigh, D. P., & Zanni, M. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805957106 · Cited by 286

Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

Verchere, C. B., D'Alessio, D. A., Palmiter, R. D., Weir, G. C., Bonner-Weir, S., Baskin, D. G., & Kahn, S. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3492 · Cited by 278

The Flavanol (−)-Epigallocatechin 3-Gallate Inhibits Amyloid Formation by Islet Amyloid Polypeptide, Disaggregates Amyloid Fibrils, and Protects Cultured Cells against IAPP-Induced Toxicity

Meng, F., Abedini, A., Plesner, A., Verchere, C. B., & Raleigh, D. P. (2010) · Biochemistry · doi:10.1021/bi100939a · Cited by 285

In vitro autoradiographic localization of amylin binding sites in rat brain

Sexton, P. M., Paxinos, G., Kenney, M. A., Wookey, P. J., & Beaumont, K. C. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90388-3 · Cited by 277

Islet amyloid polypeptide: structure, function, and pathophysiology

Akter, R., Cao, P., Noor, H., Ridgway, Z., Tu, L.-H., Wang, H., Wong, A. G., Zhang, X., Abedini, A., Schmidt, A. M., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2798269 · Cited by 273

The Impact of Disease Comorbidities in Alzheimer’s Disease

Santiago, J. A., & Potashkin, J. A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631770 · Cited by 259

An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing.

Sanke, T., Bell, G. I., Sample, C. E., Rubenstein, A. H., & Steiner, D. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77825-9 · Cited by 258

The importance of the β-cell in the pathogenesis of type 2 diabetes mellitus

Kahn, S. E. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00336-3 · Cited by 247

Amylin Agonists: A Novel Approach in the Treatment of Diabetes

Schmitz, O., Brock, B., & Rungby, J. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s233 · Cited by 237

Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes

Miklossy, J., Qing, H., Rađenović, A., Kis, A., Vileno, B., Forró, L., Miller, L. M., Martins, R. N., Waeber, G., Mooser, V., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.019 · Cited by 246

The road to the synthesis of “difficult peptides”

Paradís‐Bas, M., Tulla‐Puche, J., & Alberício, F. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00680e · Cited by 237

Recent Insights in Islet Amyloid Polypeptide‐Induced Membrane Disruption and Its Role in β‐Cell Death in Type 2 Diabetes Mellitus

Khemtémourian, L., Killian, J. A., Höppener, J. W. M., & Engel, M. F. M. (2008) · Journal of Diabetes Research · doi:10.1155/2008/421287 · Cited by 238

The Changing Face of Glucagon Fibrillation: Structural Polymorphism and Conformational Imprinting

Pedersen, J. S., Dikov, D., Flink, J. M., Hjuler, H. A., Christiansen, G., & Otzen, D. E. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.100 · Cited by 235

Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans

Karhunen, L. J., Juvonen, K. R., Huotari, A., Purhonen, A., & Herzig, K. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2007.10.008 · Cited by 240

Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases

Carniglia, L., Ramírez, D., Durand, D., Saba, J., Turati, J., Caruso, C. M., Scimonelli, T. N., & Lasaga, M. (2017) · Mediators of Inflammation · doi:10.1155/2017/5048616 · Cited by 239

The role of FOXO1 in β-cell failure and type 2 diabetes mellitus

Kitamura, T. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.157 · Cited by 224

Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure

Tyndall, J. D. A., Pfeiffer, B., Abbenante, G., & Fairlie, D. P. (2005) · Chemical Reviews · doi:10.1021/cr040689g · Cited by 230

Adiposity signals and the control of energy homeostasis

Woods, S. C., & Seeley, R. J. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00454-8 · Cited by 221

The aggregation potential of human amylin determines its cytotoxicity towards islet β‐cells

Konarkowska, B., Aitken, J. F., Kistler, J., Zhang, S., & Cooper, G. J. S. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05367.x · Cited by 219

Transcriptomes of the major human pancreatic cell types

Dorrell, C., Schug, J., Lin, C., Canaday, P. S., Fox, A. J., Smirnova, O., Bonnah, R. A., Streeter, P. R., Stoeckert, C. J., Kaestner, K. H., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2283-5 · Cited by 217

Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis

Zraika, S., Hull, R. L., Udayasankar, J., Aston‐Mourney, K., Subramanian, S. L., Kisilevsky, R., Szarek, W. A., & Kahn, S. E. (2009) · Diabetologia · doi:10.1007/s00125-008-1255-x · Cited by 215

Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation

Honda, H., Nagai, Y., Matsunaga, T., Okamoto, N., Watanabe, Y., Tsuneyama, K., Hayashi, H., Fujii, I., Ikutani, M., Hirai, Y., et al. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0114-005rr · Cited by 213

Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process

Wiltzius, J. J. W., Sievers, S. A., Sawaya, M. R., & Eisenberg, D. S. (2009) · Protein Science · doi:10.1002/pro.145 · Cited by 208

Islet Amyloid, Islet-Amyloid Polypeptide, and Diabetes Mellitus

Epstein, F. H., Johnson, K. H., O'Brien, T. D., Betsholtz, C., & Westermark, P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908243210806 · Cited by 203

Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment.

Ogawa, A., Harris, V., McCorkle, S. K., Unger, R. H., & Luskey, K. L. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114528 · Cited by 200

Amyloid β and Amylin Fibrils Induce Increases in Proinflammatory Cytokine and Chemokine Production by THP‐1 Cells and Murine Microglia

Yates, S. L., Burgess, L. H., Kocsis‐Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M., & Brunden, K. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741017.x · Cited by 202

Apoptosis in pancreatic β-islet cells in Type 2 diabetes

Tomita, T. (2016) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2016.919 · Cited by 197

Molecular links between Alzheimer’s disease and diabetes mellitus

Yang, Y., & Song, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.009 · Cited by 211

Mechanisms of islet amyloidosis toxicity in type 2 diabetes

Abedini, A., & Schmidt, A. M. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.017 · Cited by 206

Islet amyloid polypeptide and type 2 diabetes.

Marzban, L., Park, K., & Verchere, C. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00004-4 · Cited by 191

Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes

Milardi, D., Gazit, E., Radford, S. E., Xu, Y., Gallardo, R. U., Caflisch, A., Westermark, G. T., Westermark, P., Rosa, C. L., & Ramamoorthy, A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00981 · Cited by 199

Anti-obesity therapy: from rainbow pills to polyagonists

Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014803 · Cited by 199

Human Islet Amyloid Polypeptide Oligomers Disrupt Cell Coupling, Induce Apoptosis, and Impair Insulin Secretion in Isolated Human Islets

Ritzel, R. A., Meier, J. J., Lin, C., Veldhuis, J. D., & Butler, P. C. (2006) · Diabetes · doi:10.2337/db06-0734 · Cited by 197

The insulin secretory granule

Hutton, J. C. (1989) · Diabetologia · doi:10.1007/bf00265542 · Cited by 192

Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage.

Wang, X., Yue, T. L., Barone, F. C., White, R. F., Clark, R. K., Willette, R. N., Sulpizio, A. C., Aiyar, N. V., Ruffolo, R. R., Jr., & FEUERSTEIN, G. Z. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11480 · Cited by 192

Ion Mobility Spectrometry–Mass Spectrometry Defines the Oligomeric Intermediates in Amylin Amyloid Formation and the Mode of Action of Inhibitors

Young, L. M., Cao, P., Raleigh, D. P., Ashcroft, A. E., & Radford, S. E. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406831n · Cited by 190

Amyloidogenesis of Natively Unfolded Proteins

Uversky, V. N. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533312 · Cited by 188

Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes

Moreira, P. I., Santos, M. S., Seiça, R. M. F., & Oliveira, C. R. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.017 · Cited by 190

The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism

Naot, D., & Cornish, J. (2008) · Bone · doi:10.1016/j.bone.2008.07.003 · Cited by 182

Helix Stabilization Precedes Aqueous and Bilayer-Catalyzed Fiber Formation in Islet Amyloid Polypeptide

Williamson, J. A., Loria, J. P., & Miranker, A. D. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.077 · Cited by 186

Hyperproinsulinemia and Amyloid in NIDDM: Clues to Etiology of Islet β-Cell Dysfunction?

Porte, D., & Kahn, S. E. (1989) · Diabetes · doi:10.2337/diab.38.11.1333 · Cited by 185

Induction of Insulin Resistance In Vivo by Amylin and Calcitonin Gene–Related Peptide

Molina, J. M., Cooper, G. J. S., Leighton, B., & Olefsky, J. M. (1990) · Diabetes · doi:10.2337/diab.39.2.260 · Cited by 184

Toxic Human Islet Amyloid Polypeptide (h-IAPP) Oligomers Are Intracellular, and Vaccination to Induce Anti-Toxic Oligomer Antibodies Does Not Prevent h-IAPP–Induced β-Cell Apoptosis in h-IAPP Transgenic Mice

Lin, C., Gurlo, T., Kayed, R., Butler, A. E., Haataja, L., Glabe, C. G., & Butler, P. C. (2007) · Diabetes · doi:10.2337/db06-1579 · Cited by 183

Effects of in vivo conditions on amyloid aggregation

Owen, M. C., Gnutt, D., Gao, M., Wärmländer, S. K. T. S., Jarvet, J., Gräslund, A., Winter, R., Ebbinghaus, S., & Strodel, B. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00034d · Cited by 181

ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES

Clark, A., Lewis, C. E., Willis, A. C., Cooper, G. J. S., Morris, J. F., Reid, K. B. M., & Turner, R. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90825-7 · Cited by 351

Pancreatic Islet Amyloid and Diabetes

Clark, A., & Moffitt, J. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_10 · Cited by 7

A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas

Westermark, P., Wernstedt, C., Wilander, E., & Sletten, K. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90708-4 · Cited by 510

Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets

Ohsawa, H., Kanatsuka, A., Yamaguchi, T., Makino, H., & Yoshida, S. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92529-1 · Cited by 186

Antibodies specific for the pancreatic islet amyloid polypeptide associated with Type 2 diabetes mellitus

Glenner, G. G., Ceja, F., & Mehlhaff, P. M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90005-3 · Cited by 5